Is Silence Therapeutics Stock a good buy in 2026, according to Wall Street analysts?
The consensus among 2 Wall Street analysts covering (NASDAQ: SLN) stock is to Buy SLN stock.
Out of 2 analysts, 1 (50%) are recommending SLN as a Strong Buy, 0 (0%) are recommending SLN as a Buy, 1 (50%) are recommending SLN as a Hold, 0 (0%) are recommending SLN as a Sell, and 0 (0%) are recommending SLN as a Strong Sell.
According to 2 Wall Street analysts that have issued a 1 year SLN price target, the average SLN price target is $26.00, with the highest SLN stock price forecast at $32.00 and the lowest SLN stock price forecast at $20.00.
On average, Wall Street analysts predict that Silence Therapeutics's share price could reach $26.00 by Oct 21, 2027. The average Silence Therapeutics stock price prediction forecasts a potential upside of 32.25% from the current SLN share price of $19.66.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.